The results of a pilot study presented today at the Annual European Congress of Rheumatology (EULAR 2019) suggest that electro stimulation of one of the nerves connecting the brain to the body (the vagus nerve), could provide a novel treatment approach for patients with rheumatoid arthritis.
“This is a really exciting development. For many patients suffering from rheumatoid arthritis, current treatments don’t work, or aren’t tolerated,” said Professor Thomas Dörner, Chairperson of the Scientific Programme Committee, EULAR. “These results open the door to a novel approach to treating not only rheumatoid arthritis, but other chronic inflammatory diseases. This is certainly an area for further study.”
The vagus nerve is the longest and the most complex of the 12 pairs of cranial nerves that originate from the brain. The name ‘vagus’ comes from the latin word for ‘wandering’. This is because the vagus nerve wanders from the brain into the organs of the neck, chest and abdomen.
Recent advances in neuroscience and immunology have mapped circuits in the brain that regulate immune responses. In one of the circuits, the ‘inflammatory reflex’, signals are transmitted in the vagus nerve that inhibit the production of cytokines including tumor necrosis factor (TNF), an inflammatory molecule that is a major therapeutic target in rheumatoid arthritis. It is thought that, by stimulating the activity of this inflammatory reflex, innate immune responses can be modulated without abolishing them or producing significant immunosuppression.
In this pilot study, a novel miniaturised neurostimulator called a MicroRegulator was implanted into 14 patients with rheumatoid arthritis who had failed on at least two biologics or targeted oral therapies with different mechanisms of action. Patients were randomised to three groups who were either placebo, stimulated once daily, or stimulated four times a day for 12 weeks. At the end of the study, the patients who received once-daily stimulation were shown to have a better response than those on four-times-daily stimulation with two thirds meeting the EULAR good or moderate response criteria and a mean change in DAS28-CRP of -1.24. The mean change in DAS28-CRP* in the placebo group was 0.16.1
Cytokines (a broad and loose category of small proteins that are important in cell signalling) were also measured in the study with the actively stimulated groups showing a decrease of more than 30% in levels of Interleukin (IL) 1?, IL-6, and TNF-?. Implantation and stimulation were generally well tolerated with no device or treatment-related SAEs and two surgery-related adverse events that resolved without clinically significant effects.
“Our pilot study suggests this novel MicroRegulator device is well tolerated and reduces signs and symptoms of rheumatoid arthritis,” said Mark Genovese, M.D., James W. Raitt Endowed Professor of Medicine, Stanford University, Stanford, California, USA. “These data support the study of this device in a larger placebo-controlled study as a novel treatment approach for rheumatoid arthritis and possibly other chronic inflammatory diseases.”
This study follows a proof-of-concept study which used reprogrammed epilepsy stimulators on the vagus nerve to demonstrate reduced systemic inflammation and improved disease activity in 17 patients with rheumatoid arthritis.
The study included 14 patients with active rheumatoid arthritis who had had an insufficient response to more than two biological disease modifying anti-rheumatic drugs (bDMARDs) or JAK inhibitors with more than two modes of action. All patients remained on stable background of methotrexate. The first three patients were implanted and stimulated after three weeks, following safety review board approval, the remaining 11 patients were implanted and randomised to one minute of stimulation once-daily, one minute of stimulation four times daily, or one minute of placebo stimulation.
The Latest on: Electro stimulation
via Google News
The Latest on: Electro stimulation
- IDTechEx Forecasts Peripheral Nerve Stimulation Market to Grow at 35% CAGR, 2019-2029on July 3, 2019 at 11:53 am
Bioelectronic medicine refers to devices that use electrical stimulation to treat health conditions. The most common of these devices is the pacemaker, but there are others being used to treat ... […]
- Deep-Brain Stimulation Improves Some Urinary Function in Patients With Parkinson Diseaseon July 3, 2019 at 7:37 am
For patients who do not respond to conservative treatments, clinical researchers often recommend DBS surgery, which applies high-frequency electrical stimulation to deep brain structures. The ... […]
- Electroceutical Devices Market Trends Estimates High Demand By 2026on July 3, 2019 at 6:54 am
It includes any type of electrical stimulation, which affects and modify functions of the body and neural implants such as cochlear implants, retinal implants or spinal cord stimulators, cardiac ... […]
- Stimulation Therapies Market Report 2018: Market Trends, Leading Players, Key Developments, and Future Strategieson July 2, 2019 at 5:28 am
Rockville, MD -- (SBWIRE) -- 07/02/2019 -- Stimulation therapies use electrical impulses for stimulating muscles and improving muscle sensation and strength for soft tissue injuries. Stimulation ... […]
- OU Medicine study reveals promising results for treatmenton July 1, 2019 at 9:01 pm
But it can be stimulated on the ear. Stavrakis’ hypothesis was that an electrical stimulation on the vagus nerve could suppress atrial fibrillation. His trial was the first to study the treatment in ... […]
- Neurotechnology holds promise for chronic stroke patientson July 1, 2019 at 6:43 am
The interventions analyzed in the paper included robotics, functional electrical stimulation of muscles, brain stimulation and brain-computer interfaces as well as their use in combination. The ... […]
- Neurostimulation Devices Market Industry Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Studyon July 1, 2019 at 2:40 am
Get Customization: https://www.fortunebusinessinsights.com/enquiry/customization/neurostimulation-devices-market-100561 The wearable device is worn on the head with needles injected at three points ... […]
- Global Deep Brain Stimulation (DBS) Devices Market Outlook 2019-2024: Novel Applications Bode Tremendous Prospectson June 25, 2019 at 11:55 pm
INDUSTRY OVERVIEWA PreludeIntroduction to Deep Brain Stimulation DevicesDeep Brain ... Promise Ease of TreatmentVisual Depiction of Electrical Field Comes to the Aid of ProgrammingDevice ... […]
- Does stimulation of the brain's dorsal anterior insula trigger ecstasy?on June 24, 2019 at 8:51 am
They studied functional connectivity changes in several brain areas during the induction of ecstatic auras by direct electrical stimulation of the dorsal anterior insular cortex in patients ... […]
- Get into shape with electro muscle stimulationon June 23, 2019 at 8:05 pm
Appropriated from the medical field, electro muscle stimulation (EMS) could be the answer for busy executives and rehabilitation from physical injury. Initially developed by German researchers to help ... […]
via Bing News